SCHEMBL6097859

SCHEMBL6097859

O=c1cc(-c2ccc(Cl)cc2)oc2cccc(O)c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 13/20 1.00
▸ CYP3A4 P08684 4/20 0.78
▸ MAPT P10636 4/20 0.78
▸ MEN1 O00255 4/20 0.78
▸ KMT2A Q03164 4/20 0.78
▸ MAPK1 P28482 2/20 0.78
▸ RAF1 P04049 1/20 0.78
▸ HPGD P15428 1/20 0.78
▸ ALOX15 P16050 2/20 0.75
▸ ALDH1A1 P00352 1/20 0.75
▸ CYP1A1 P04798 1/20 0.75
▸ CYP1A2 P05177 1/20 0.75
▸ PKM P14618 1/20 0.75
▸ SMN1; SMN2 Q16637 1/20 0.75
▸ CYP1B1 Q16678 1/20 0.75
▸ FTO Q9C0B1 1/20 0.75
▸ KDM4E B2RXH2 1/20 0.71
▸ ALOX5 P09917 1/20 0.71
▸ CYP2C9 P11712 1/20 0.71
▸ ALOX12 P18054 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL157490 0.88 AR (1.00) ARCYP3A4MAPTMEN1KMT2A
5-Hydroxyflavone SCHEMBL30630415 0.86 AR (1.00) ARCYP3A4MAPTMEN1KMT2A
5-Hydroxyflavone SCHEMBL158303 0.86 AR (1.00) ARCYP3A4MAPTMEN1KMT2A
5-Hydroxyflavone SCHEMBL2390993 0.86 AR (1.00) ARCYP3A4MAPTMEN1KMT2A
SCHEMBL12636899 0.85 AR (1.00) ARCYP3A4MAPTMEN1KMT2A
5-Hydroxyflavone SCHEMBL28317755 0.84 AR (0.97) ARCYP3A4MAPTMEN1KMT2A
5-Hydroxyflavone SCHEMBL2390943 0.84 AR (0.97) ARCYP3A4MAPTMEN1KMT2A
SCHEMBL6094870 0.84 CYP3A4 (0.85) ARCYP3A4MAPTMEN1KMT2A
SCHEMBL3189987 0.84 MEN1 (0.81) ARCYP3A4MAPTMEN1KMT2A
SCHEMBL3817277 0.83 CYP3A4 (1.00) ARCYP3A4MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7009062-B2 Process for the preparation of flavone derivatives MERCK PATENT GMBH (DE) 2006-03-07 — — US disclosed
EP-1355898-B1 METHOD FOR PRODUCING FLAVONE DERIVATIVES MERCK PATENT GMBH (DE) 2005-10-12 — — EP disclosed
US-20040059100-A1 Process for the preparation of flavone derivatives EUROPEAN BRAND PARTICIPATIONS SA (LU) 2004-03-25 — — US disclosed
EP-1355898-A1 METHOD FOR PRODUCING FLAVONE DERIVATIVES MERCK PATENT GmbH (DE) 2003-10-29 — — EP disclosed
WO-2002060889-A1 METHOD FOR PRODUCING FLAVONE DERIVATIVES MERCK PATENT GMBH (DE) 2002-08-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040059100-A1 Process for the preparation of flavone derivatives HK2, MAP2K5, MAP2K4 AR 2913/4885CYP3A4 38/4885MAPT 842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback